Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
Background: Systemic insulin resistance (IR) is a primary feature in non-alcoholic steatohepatitis (NASH), however, there remain limited data on tissue-specific insulin sensitivity in vivo. Methods: We examined tissue-specific (adipose, muscle and liver) insulin sensitivity and inflammation in 16 Eu...
Main Authors: | Armstrong, M, Hazlehurst, J, Hull, D, Guo, K, Borrows, S, Yu, J, Gough, S, Newsome, P, Tomlinson, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Blackwell Publishing Ltd
2014
|
Similar Items
-
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.
by: Armstrong, M, et al.
Published: (2014) -
Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis
by: Armstrong, M, et al.
Published: (2013) -
Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo.
by: Hazlehurst, J, et al.
Published: (2013) -
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
by: Armstrong, M, et al.
Published: (2015) -
Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
by: Armstrong, M, et al.
Published: (2013)